Subject
Cardiology and Cardiovascular Medicine
Reference7 articles.
1. Idraparinux versus standard therapy for venous thromboembolic disease;Buller;N Engl J Med,2007
2. Extended prophylaxis of venous thromboembolism with idraparinux;Buller;N Engl J Med,2007
3. Reversible biotinylated oligosaccharides, a new approach for a better management of the anticoagulant therapy (abstract);Savi;J Thromb Haemost,2007
4. Comparison of idraparinux with vitamine K antagonists for prevention of thromboembolism in patients with atrial fibrillation: a randomised, open-label, non inferiority trial;Lancet,2008
5. Harenberg J, Jörg I, Vukojevic Y, Mikus G, Weiss C. Anticoagulant effects of idraparinux after termination of therapy for prevention of recurrent venous thromboembolism: observations from the van Gogh trials. Eur J Clin Pharmacol 2008 (Epub ahead of print).